Addex Therapeutics Income Statement (2022-2025) | ADXN

Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B-0.03B-0.40B0.00B
Cost of Revenue 0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Gross Profit 0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Operating items
Depreciation & Amortization - Total -0.00B-0.00B
Research & Development -0.00B-0.01B-0.00B0.02B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B
Share-based Compensation (IS) 1,370.16B578.04B809.35B331.21B395.26B398.46B298.89B0.00B0.04B27.27B0.00B0.02B
Selling, General & Administrative -0.00B-0.00B-0.00B0.01B-0.00B-0.00B-0.00B0.01B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B
Other Operating Expenses 0.000.00-0.04B0.00-0.01B0.00B0.00B-0.01B
Operating Expenses -0.01B-0.01B-0.00B-0.01B-0.00B-0.00B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Operating Income -0.01B-0.01B-0.00B-0.02B-0.00B-0.00B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
EBIT -0.01B-0.01B-0.00B-0.02B-0.00B-0.00B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Non-operating items
Interest & Investment Income 102.87212.850.00B0.00B0.00B0.00B0.00B0.00B0.00B-0.00B-0.00B0.00B17.89B-19.43B0.00B
Other Non Operating Income -42.05B0.00B0.00B-0.00B-27.65B-153.37B28.74B155.67B52.65B-30.23B-34.58B12.95B-20.69B0.00B-0.43B
Non Operating Income 0.00B0.00B-0.00B-0.00B0.00B166.14B-42.13B-126.46B-0.00B-111.22B38.31B76.92B
Net income details
EBT -0.01B-0.01B-0.00B0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B17.89B-0.00B
Profit After Tax -0.01B-0.01B-0.00B-0.02B-0.00B-0.00B-0.00B-0.01B-0.00B10,827.37B-0.00B-0.00B-1638.19B-0.00B
Equity Income -0.00B0.01B0.01B0.01B-0.00B
Income from Continuing Operations -0.01B-0.01B-0.00B0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B17.89B-0.00B
Consolidated Net Income -0.01B-0.01B-0.00B0.01B-0.00B-0.00B-0.00B-0.00B-0.00B0.02B-0.00B-0.00B17.89B-0.00B
Income towards Parent Company -0.01B-0.01B-0.00B0.01B-0.00B-0.00B-0.00B-0.00B-0.00B0.02B-0.00B-0.00B17.89B-0.00B
Net Income towards Common Stockholders -0.16-0.20-0.09-0.02B-0.04-0.04-0.03-0.01B-0.030.14-0.020.01B-0.01-0.01
Additional items
EPS (Basic) 0.000.000.00-0.570.000.000.00-0.160.000.000.000.080.000.00
EPS (Weighted Average and Diluted) 0.000.00
Shares Outstanding (Weighted Average) 0.04B0.04B0.04B0.04B0.06B0.06B0.07B0.07B0.07B0.10B0.10B0.10B0.10B0.10B0.10B
Shares Outstanding (Diluted Average) 0.04B0.08B
EBITDA -0.01B-0.01B-0.00B-0.02B-0.00B-0.00B-0.00B-0.01B-0.00B0.01B-0.00B-0.00B-0.00B-0.00B-0.00B
Interest Expenses -0.00B-0.00B0.00B0.00B-0.00B-0.00B0.00B0.00B-700.01-955.41-0.00B0.00B-0.00B-0.00B